Ironic Biotech develops patented, non-animal heme iron compounds for use in food fortification and supplements. These compounds offer high bioavailability and stability without imparting taste, addressing widespread iron deficiency. The company provides a science-based solution to improve human health outcomes related to insufficient iron levels.
Funding
$1.1M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Iron deficiency affects billions globally, leading to fatigue, cognitive issues, and other health problems. Current iron supplements often cause gastrointestinal discomfort and are poorly absorbed by the body.
Solution
Ironic Biotech develops patented non-animal heme iron compounds using precision fermentation to address iron deficiency. These compounds offer high bioavailability and stability for incorporation into food products and supplements. Produced sustainably from common edible plants, the compounds are tasteless, addressing the common issue of taste aversion with existing supplements. Ironic Biotech collaborates with food companies to incorporate its bioavailable iron directly into their products, offering a more effective and palatable solution to combat iron deficiency.
Target Audience
The primary target audience includes food companies seeking to fortify their products with highly bioavailable iron, as well as individuals, particularly women, children, vegetarians, vegans, and those with chronic illnesses, who are susceptible to iron deficiency.
Features
- Patented non-animal heme iron compounds produced via precision fermentation
- High bioavailability comparable to iron found in meat
- Tasteless and stable for easy incorporation into food and supplements
- Sustainable production from common edible plants